The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Independent Certified Satellite Symposium Treatment Advances with Novel Anti-Androgen Therapy, PARP Inhibitors, and NGI For Hormone-Sensitive and Castration-Resistant Prostate Cancer